Coalition to Advance Maternal Therapeutics

RECENT COALITION NEWS & ACTIVITIES:

December 27, 2021: Members of CAMT joined a letter to Congressional sponsors of the Cures 2.0 Act urging them include provisions to advance maternal therapeutics in the legislative package.

June 1, 2021: CAMT sent a letter to Secretary Becerra outlining opportunities for the U.S. Department of Health and Human Services to promote the inclusion of pregnant and lactating people in clinical trials.

March 24, 2021: CAMT sent a letter to President Biden and Vice President Harris highlighting policy changes necessary to promote the inclusion of pregnant and lactating people in clinical trials.

March 1, 2021: CAMT sent a letter to the CDC’s Advisory Committee on Immunization Practices regarding access to the Janssen Biotech Inc. COVID-19 vaccine for pregnant and lactating people.

February 25, 2021: CAMT sent a letter to the FDA’s Vaccines and Related Biological Products Advisory Committee on access to the Janssen Biotech Inc. COVID-19 vaccine for pregnant and lactating people.

September 8, 2020: CAMT sent a letter with 22 signers urging FDA’s Office of Women’s Health to include promoting the inclusion of pregnant women and lactating women in clinical trials as a primary strategic priority.

June 24, 2020: PRGLAC met to discuss implementation of its September 2018 report to the U.S. Health and Human Services Secretary Alex Azar. CAMT provided public comments during the meeting.

May 6, 2020: CAMT issues a new one-pager on the development of vaccines and treatments related to COVID-19

March 18, 2020: CAMT writes to the NIH and FDA to call for inclusion of pregnant and lactating women in clinical trials related to COVID-19

August 22-23, 2019: The Task Force Specific to Pregnant Women and Lactating Women (PRGLAC) met to discuss the implementation of its September 2018 report to U.S. Health and Human Services Secretary Alex Azar. CAMT provided public comments during the meeting.

February 26, 2019: The PRGLAC Task Force is extended! In February 2019, HHS announced that it was reviewing the Task Force recommendations in order to better facilitate research in pregnancy and would extend the work of the Task Force.

October 24, 2018: The Coalition to Advance Maternal Therapeutics wrote to Secretary Azar urging him to implement the recommendations of the PRGLAC as soon as possible.

June 20, 2017: SMFM and members of the Steering Committee of the Coalition to Advance Maternal Therapeutics wrote to Secretary Price to ask that he move quickly and approve a slate of members for the Task Force on Research Specific to Pregnant Women and Lactating Women.

MEMBER ORGANIZATIONS

Academy of Breastfeeding Medicine
American Academy of Pediatrics *
American Academy of Allergy, Asthma & Immunology's Vaccines and Medications in Pregnancy Surveillance System
American College of Nurse-Midwives
American Association of Colleges of Pharmacy
American College of Obstetricians and Gynecologists *
American Heart Association
Association of Maternal & Child Health Programs
Association of Women’s Health, Obstetric, and Neonatal Nurses
Elizabeth Glaser Pediatric AIDS Foundation
Endocrine Society
Epilepsy Foundation
Genetic Alliance
March of Dimes *
Maternal Mental Health Leadership Alliance
National Association of Nurse Practitioners in Women’s Health
North American Society for Psychosocial Obstetrics & Gynecology
Organization of Teratology Information Specialists
Society for Birth Defects Research and Prevention
Society for Obstetric Anesthesia and Perinatology
Society for Maternal-Fetal Medicine*
Society of OB/GYN Hospitalists
Society for Women’s Health Research*
Treatment Action Group
United States Breastfeeding Committee
WomenHeart: National Coalition for Women with Heart Disease

* Denotes Steering Committee Member